Trial intelligence / Profile preview

Pilot Effectiveness of Randomised Mandatory Insulin Therapy

2005-001693-27Phase 4Completed

Sponsor
Oxford University Hospitals
Start
Apr 2005
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, randomised trial of human insulin in critical illness (2 arms), sponsored by Oxford University Hospitals. Primary endpoint: Hypoglycaemia episodes per ICU stay length. Started Apr 2005; status: completed.

02

Drugs

human insulin
03

Conditions

critical illness

Beyond the preview

Go deeper on 2005-001693-27.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-001693-27.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call